WorldWide D-dimer Market, Industry / Sector Analysis Report, Regional Outlook & Competitive Market Share & Forecast, 2019 - 2025 (Includes Business Impact of COVID-19)

                                          
D-dimer Market size is projected to experience significant growth from 2017 to 2024.
 

Increasing demand for D-dimer tests due to high accuracy, cost effectiveness, and lack of radiological interventions will drive the global D-dimer market size. Growing prevalence of high level d-dimer in women at an early age due to higher burden of associated diseases will boost the industry size. Moreover, increase in occurrence of cardiovascular and pulmonary diseases coupled with growing demand for advanced coagulation testing techniques and rising lifestyle induced diseases will fuel the product demand over the forecast years.
 

The increasing cost-containment pressures in major established nations and constant technological advances will radically change coagulation testing practice during the forecast period. Technological advancements have contributed majorly in reducing the cost associated with tests at POCs and laboratories. Stringent regulatory guidelines for listing of devices and manufacturing practice may hamper d-dimer market growth. Low specification when used in special setting such as in oncology patients, elderly patients, and pregnant women can limit industry size.
 

Based on application, the industry is segmented into deep venous thrombosis testing, pulmonary embolism testing and disseminated intravascular coagulation testing. Pulmonary embolism testing market is estimated to dominate the industry due to its growing prevalence among geriatric population. Deep venous thrombosis (DVTs) testing is also likely to grow at a substantial rate over the forecast period. 
 

Pulmonary Embolism (PE) is the third-most-common cause of death in the U.S., after heart attack and stroke. According to American Society for Clinical Pathology, thromboembolic disease, which comprises DVTs, PEs, and associated medical complications, marks more than 600,000 people in the country each year and generates approximately USD 10 billion.
 

Europe will experience a substantial growth with mounting clinical trial, technological advancement, and therapeutic practices. The National Health Service (NHS) records around 1 person in 1,000 with DVT in the U.K. every year. Increasing opportunities to implement rapid diagnostic testing to improve operations, improved health care awareness, and preference of the people for preventive health checkups will fuel the industry size.
 

Asia Pacific is forecast to grow at highest rate with increasing number of patients demanding test for coagulation as well as introduction of more sensitive and specific markers of hemostasis on automated instruments. Diagnostic laboratories are facing challenges in delivering high-quality, efficient and timely testing solutions due to rising health care awareness and stringent regulations that pressurize health care budgets.
 

Brazil d-dimer market will dominate Latin America during the forecast period due to rising incidence rates of cardiovascular diseases associated with changing lifestyle habits. South Africa witnessed the highest share in MEA region owing to growing elderly population, prevalence of higher d-dimer levels in black race and female sex.
 

Some of the industry players in d-dimer market include Abbott Laboratories, F. Hoffman-La Roche, Beckman Coulter, Alere, Bio/Data, Becton Dickinson, Sysmex, Siemens Healthcare, Trinity Biotech and Thermo Fisher Scientific. Competition is growing among industry players across all regions with increasing technological advancements.